End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.82 CNY | +1.48% | +4.49% | -20.22% |
04-25 | Doctorglasses Chain Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | Doctorglasses Chain Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 55% by 2026.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.22% | 381M | - | ||
-3.37% | 4.25B | B- | ||
-14.48% | 1.41B | C | ||
+11.35% | 701M | - | ||
-30.64% | 498M | - | ||
+23.06% | 192M | - | - | |
-21.01% | 135M | - | - | |
-7.37% | 133M | - | ||
+0.33% | 92.65M | - | - | |
+4.93% | 72.62M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300622 Stock
- Ratings Doctorglasses Chain Co.,Ltd.